Public Company News

Terrain Minerals has kicked off a maiden air-core drilling campaign at its Larins Lane base metals-gold-silver prospect to test for what it believes could be a deposit analogous to 29Metals’ hulking Golden Grove operation in Western Australia’s Mid West region. The company plans to drill 145 holes for 2500m in two priority categories on three separate main targets and a handful of unexplained anomalies.

Si6 Metals’ latest batch of drill assays from its Dibete project in Botswana show a hole with a bumper copper grade of 13 per cent, paired with 168g/t silver in a 1m section from 29m. The eye-catching chunk was within a 6.15m section going 7.2 per cent copper and 182g/t silver from 24.85m, including 0.5m at 10.8 per cent copper and 281g/t silver.

Ora Banda Mining has added significant momentum to its drive towards producing 100,000 ounces of gold annually by 2025 after intersecting the first ore from its Riverina underground’s Main Lode, some four weeks ahead of schedule. The company expects to mine a lode grade of 10g/t gold at Riverina as part of its “Drive to 100” campaign.

Aurum Resources is set to take its gold search to a new continent after signing a binding agreement to acquire PlusOr Global, which holds the rights to earn into the Boundiali gold project in Côte d’Ivoire. The project on the southern coast of West Africa covers two contiguous granted exploration permits within Côte d’Ivoire's prospective Boundiali greenstone belt.

Quantum Graphite believes more than doubling its mill throughput up to 1.2 million tonnes a year at its Uley 2 project in South Australia will lead to improved economics, following an independent assessment. The study by Lycopodium Minerals also looks into increasing production at the operation from 55,000 dry metric tonnes of flake graphite up to a maximum of 100,000 dry metric tonnes.

An independent carbon capture and storage study on Buru Energy’s Canning Basin blocks has strengthened the “commercialisation pathway” for it to develop its Rafael conventional gas and condensate discovery. Buru’s subsidiary GeoVault recently found the blocks to be capable of holding significantly more carbon dioxide than Rafael is modelled to produce, supporting the company’s development strategy for the field.

Following several recent divestments, Aurumin has made good its promise to home in on its 946,000-ounce Sandstone gold project in Western Australia’s Mid West region after revealing it had secured three new exploration licences. The move more than doubles the company’s presence in the central project area as it gets closer to eradicating an overhanging $6.4 million debt relating to its Sandstone acquisition last year.

American West Metals has confirmed outstanding grades of 38.2 per cent copper and 30.87 per cent zinc from geochemical sampling at the Tempest prospect that forms part of its greater Storm project in Canada. The results came from surface gossan rocks at the underexplored site, which have been mapped for more than 4km and are about 40km south of copper targets drilled earlier this year.

This week’s Bulls N’ Bears profiled ASX runner is… Chariot Corporation. Its shares doubled this week to join movers including Pure Resources, Sunshine Metals and Roots Sustainable Agricultural Technologies.

Aurumin has continued to level its exploration and financial focus further on its Sandstone gold project in Western Australia after selling the iron ore rights at its Mt Dimer operation to a subsidiary of Mineral Resources. It will retain exposure through progress and royalty payments as part of a $250,000 sale to Polaris Metals for iron ore rights at four of its Mt Dimer tenements.

Strickland Metals has emerged as one of the ASX’s runners of the year, jumping 400 per cent to an 11-year high of 20 cents on Thursday, on the back of more drilling at its Marwari gold prospect near Wiluna in WA. Led by entrepreneurial boss Andrew Bray, Stickland sits as the lone gold explorer among a sea of lithium hopefuls leading this year’s ASX charge.

Chimeric Therapeutics’ mission to beat cancer with its “natural killer” therapy has hit a new high point, with test-tube studies showing a 300 per cent increase in its ability to kill the pancreatic form of the insidious disease. The company’s latest revelations also show its off-the-shelf “CLTX CAR NK” cell therapy recording a 260 per cent jump in killing ovarian cancer.